Inventor · disambiguated record
Ihab Darwish
Also filed as: DARWISH IHAB · DARWISH IHAB S
57 granted patents·11 pending applications·187 citations·filing 2001–2024
98Inventor score
Files withRIGEL PHARMACEUTICALS INC54DARWISH IHAB S3NUVATION BIO INC3BHAMIDIPATI SOMASEKHAR2HONG HUI2
Top patents by PatentIndex Score
68 records- 0197US11407736B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·4 cites·8 claims
- 0297US10975064B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·14 cites·18 claims
- 0396US11584758B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Feb 21, 2023·5 cites·37 claims
- 0494US11834458B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2022·Granted Dec 5, 2023·2 cites·34 claims
- 0594US11370787B2Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·4 cites·23 claims
- 0693US12006314B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2022·Granted Jun 11, 2024·2 cites·17 claims
- 0793US9475781B2Fumarate analogs and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Oct 25, 2016·11 cites·28 claims
- 0891US8309566B2Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinasesBHAMIDIPATI SOMASEKHAR·Filed 2009·Granted Nov 13, 2012·17 cites·26 claims
- 0991US8119809B2AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the sameHONG HUI·Filed 2008·Granted Feb 21, 2012·17 cites·27 claims
- 1089US10822337B2TGF-β inhibitorCRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Nov 3, 2020·4 cites·16 claims
- 1189US8569340B2AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the sameHONG HUI·Filed 2012·Granted Oct 29, 2013·12 cites·27 claims
- 1289US7176310B1Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agentsUCB SA·Filed 2003·Granted Feb 13, 2007·29 cites·11 claims
- 1388US11919890B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·1 cites·18 claims
- 1488US11110082B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Sep 7, 2021·2 cites·28 claims
- 1587US8314107B2Carboxamide compounds and methods for using the sameYU JIAXIN·Filed 2009·Granted Nov 20, 2012·9 cites·40 claims
- 1687US2024368119A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1786US8129390B2Carboxamide, sulfonamide and amine compounds and methods for using the sameDARWISH IHAB S·Filed 2008·Granted Mar 6, 2012·9 cites·53 claims
- 1886US8012955B2N-substituted-heterocycloalkyloxybenzamide compounds and methods of useRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Sep 6, 2011·7 cites·70 claims
- 1984US9801866B2Fumarate analogs and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Oct 31, 2017·3 cites·27 claims
- 2084US8735418B2Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinasesBHAMIDIPATI SOMASEKHAR·Filed 2012·Granted May 27, 2014·8 cites·22 claims
- 2183US10434096B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Oct 8, 2019·2 cites·6 claims
- 2283US8785449B2Carboxamide compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Jul 22, 2014·4 cites·32 claims
- 2382US2025092057A1Heterocyclic rip1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2481US12441723B2Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted Oct 14, 2025·0 cites·19 claims
- 2581US10130623B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Nov 20, 2018·2 cites·39 claims
- 2681US2024217958A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2780US2023112865A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2878US9884868B2TGF-beta inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Feb 6, 2018·2 cites·36 claims
- 2977US12227508B2TGF-β inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Feb 18, 2025·0 cites·22 claims
- 3076US8846600B2Carboxamide compounds and methods for using the sameDARWISH IHAB S·Filed 2012·Granted Sep 30, 2014·3 cites·27 claims
- 3176US2023143161A1Heterocyclic rip1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3275US12297202B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted May 13, 2025·0 cites·4 claims
- 3375US11672791B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Jun 13, 2023·0 cites·20 claims
- 3475US7776847B2Benzisothiazoles useful for treating or preventing HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Aug 17, 2010·3 cites·5 claims
- 3574US8871770B2Carboxamide compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Oct 28, 2014·1 cites·37 claims
- 3674US8557822B2Carboxamide, sulfonamide and amine compounds and methods for using the sameDARWISH IHAB S·Filed 2012·Granted Oct 15, 2013·2 cites·51 claims
- 3774US2024352027A1Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2023·Application pending·0 cites
- 3873US12043629B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted Jul 23, 2024·0 cites·5 claims
- 3973US7498353B2Heterocyclic anti-viral compounds comprising metabolizable moieties and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 3, 2009·2 cites·24 claims
- 4072US11129819B2Fumarate analogs and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Sep 28, 2021·0 cites·22 claims
- 4171US11578078B2Heterocyclic RIP1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·18 claims
- 4271US9174964B2AMPK-activating piperidinyloxy-substituted 2,3-dihydro-1H-indene-1-amine compounds and pharmaceutical compositions including the sameRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Nov 3, 2015·1 cites·23 claims
- 4371US8697727B2N-substituted-heterocycloalkyloxybenzamide compounds and methods of useSINGH RAJINDER·Filed 2011·Granted Apr 15, 2014·1 cites·26 claims
- 4470US2022306620A1Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4569US11466018B2TGF-β inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Oct 11, 2022·0 cites·16 claims
- 4669US8362235B2Carboxamide compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·1 cites·24 claims
- 4767US11667643B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·0 cites·19 claims
- 4865US9062052B2Carboxamide compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Jun 23, 2015·0 cites·43 claims
- 4964US12459941B2Tricyclic IRAK inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·13 claims
- 5064US10851093B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 1, 2020·0 cites·17 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →